RYAH Group, engaged in the development and commercialization of various innovative technology solutions for the plant-based medical industry, was featured in The Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. RYAH’s CEO Gregory Wagner joined the latest episode to discuss the company’s 2021 goals and milestones, as well as provide an overview of RYAH’s business model and product offerings. “I came to the company two years ago, and the reason why I came here from a different career was because I was completely floored by the amount of data this company had been collecting over years in plant-based medicine,” Wagner said. “Essentially the company’s mission is both devices and data. I like to think of the company as a pioneering IoT device and digital care platform. We’re designed to capture complex datapoints to better enable doctors and clinics to create highly customized, personalized dosing regiments… and also to help governments make better regulatory decisions around plant-based medicine based on the data that we can provide and hopefully, eventually, encourage Big Pharma to make medical breakthroughs in plant-based medicine with our data analytics.”
To view the full press release, visit https://ibn.fm/Fjo5R
About RYAH Group Inc.
RYAH is a company operating out of New York, which, directly and through its wholly owned subsidiary RYAH Medtech Inc., is engaged in the development and commercialization of various innovative technology solutions (both software and hardware) for the plant-based medical industry. Since its formation, RYAH Group has been focused on leveraging its know-how in predictive analytics to pioneer products to be used within its suite of vertically integrated technologies to provide users with added control over their health and wellness. As an emerging company, RYAH is striving to establish itself as a leader in delivering innovative, user-friendly IoT devices in the plant-based medical industry. By utilizing its know-how in fields such as artificial intelligence and predictive analytics, the company is moving towards building a portfolio of vertically integrated products that facilitate harmonized data collection throughout the complete medical plant lifecycle, from seed to consumption. For more information about the company, please visit www.RYAHGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://ibn.fm/RYAH
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.